Cargando…
Evaluation of options for harvest of a recombinant E. Coli fermentation producing a domain antibody using ultra scale‐down techniques and pilot‐scale verification
Ultra scale‐down (USD) methods operating at the millilitre scale were used to characterise full‐scale processing of E. coli fermentation broths autolysed to different extents for release of a domain antibody. The focus was on the primary clarification stages involving continuous centrifugation follo...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991298/ https://www.ncbi.nlm.nih.gov/pubmed/26698375 http://dx.doi.org/10.1002/btpr.2220 |
_version_ | 1782448836188307456 |
---|---|
author | Voulgaris, Ioannis Chatel, Alex Hoare, Mike Finka, Gary Uden, Mark |
author_facet | Voulgaris, Ioannis Chatel, Alex Hoare, Mike Finka, Gary Uden, Mark |
author_sort | Voulgaris, Ioannis |
collection | PubMed |
description | Ultra scale‐down (USD) methods operating at the millilitre scale were used to characterise full‐scale processing of E. coli fermentation broths autolysed to different extents for release of a domain antibody. The focus was on the primary clarification stages involving continuous centrifugation followed by depth filtration. The performance of this sequence was predicted by USD studies to decrease significantly with increased extents of cell lysis. The use of polyethyleneimine reagent was studied to treat the lysed cell broth by precipitation of soluble contaminants such as DNA and flocculation of cell debris material. The USD studies were used to predict the impact of this treatment on the performance and here it was found that the fermentation could be run to maximum productivity using an acceptable clarification process (e.g., a centrifugation stage operating at 0.11 L/m(2) equivalent gravity settling area per hour followed by a resultant required depth filter area of 0.07 m(2)/L supernatant). A range of USD predictions was verified at the pilot scale for centrifugation followed by depth filtration. © 2016 The Authors Biotechnology Progress published by Wiley Periodicals, Inc. on behalf of American Institute of Chemical Engineers Biotechnol. Prog., 32:382–392, 2016 |
format | Online Article Text |
id | pubmed-4991298 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-49912982016-09-06 Evaluation of options for harvest of a recombinant E. Coli fermentation producing a domain antibody using ultra scale‐down techniques and pilot‐scale verification Voulgaris, Ioannis Chatel, Alex Hoare, Mike Finka, Gary Uden, Mark Biotechnol Prog Bioseparations and Downstream Processing Ultra scale‐down (USD) methods operating at the millilitre scale were used to characterise full‐scale processing of E. coli fermentation broths autolysed to different extents for release of a domain antibody. The focus was on the primary clarification stages involving continuous centrifugation followed by depth filtration. The performance of this sequence was predicted by USD studies to decrease significantly with increased extents of cell lysis. The use of polyethyleneimine reagent was studied to treat the lysed cell broth by precipitation of soluble contaminants such as DNA and flocculation of cell debris material. The USD studies were used to predict the impact of this treatment on the performance and here it was found that the fermentation could be run to maximum productivity using an acceptable clarification process (e.g., a centrifugation stage operating at 0.11 L/m(2) equivalent gravity settling area per hour followed by a resultant required depth filter area of 0.07 m(2)/L supernatant). A range of USD predictions was verified at the pilot scale for centrifugation followed by depth filtration. © 2016 The Authors Biotechnology Progress published by Wiley Periodicals, Inc. on behalf of American Institute of Chemical Engineers Biotechnol. Prog., 32:382–392, 2016 John Wiley and Sons Inc. 2016-01-12 2016 /pmc/articles/PMC4991298/ /pubmed/26698375 http://dx.doi.org/10.1002/btpr.2220 Text en © 2016 The Authors Biotechnology Progress published by Wiley Periodicals, Inc. on behalf of American Institute of Chemical Engineers This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Bioseparations and Downstream Processing Voulgaris, Ioannis Chatel, Alex Hoare, Mike Finka, Gary Uden, Mark Evaluation of options for harvest of a recombinant E. Coli fermentation producing a domain antibody using ultra scale‐down techniques and pilot‐scale verification |
title | Evaluation of options for harvest of a recombinant E. Coli fermentation producing a domain antibody using ultra scale‐down techniques and pilot‐scale verification |
title_full | Evaluation of options for harvest of a recombinant E. Coli fermentation producing a domain antibody using ultra scale‐down techniques and pilot‐scale verification |
title_fullStr | Evaluation of options for harvest of a recombinant E. Coli fermentation producing a domain antibody using ultra scale‐down techniques and pilot‐scale verification |
title_full_unstemmed | Evaluation of options for harvest of a recombinant E. Coli fermentation producing a domain antibody using ultra scale‐down techniques and pilot‐scale verification |
title_short | Evaluation of options for harvest of a recombinant E. Coli fermentation producing a domain antibody using ultra scale‐down techniques and pilot‐scale verification |
title_sort | evaluation of options for harvest of a recombinant e. coli fermentation producing a domain antibody using ultra scale‐down techniques and pilot‐scale verification |
topic | Bioseparations and Downstream Processing |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991298/ https://www.ncbi.nlm.nih.gov/pubmed/26698375 http://dx.doi.org/10.1002/btpr.2220 |
work_keys_str_mv | AT voulgarisioannis evaluationofoptionsforharvestofarecombinantecolifermentationproducingadomainantibodyusingultrascaledowntechniquesandpilotscaleverification AT chatelalex evaluationofoptionsforharvestofarecombinantecolifermentationproducingadomainantibodyusingultrascaledowntechniquesandpilotscaleverification AT hoaremike evaluationofoptionsforharvestofarecombinantecolifermentationproducingadomainantibodyusingultrascaledowntechniquesandpilotscaleverification AT finkagary evaluationofoptionsforharvestofarecombinantecolifermentationproducingadomainantibodyusingultrascaledowntechniquesandpilotscaleverification AT udenmark evaluationofoptionsforharvestofarecombinantecolifermentationproducingadomainantibodyusingultrascaledowntechniquesandpilotscaleverification |